Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Very long-chain acyl-CoA dehydrogenase deficiency nomenclature: compound heterozygosity

Journal of Human Genetics volume 65, pages 435–436 (2020)Cite this article

Subjects

As recently reviewed [1], very long-chain acyl-CoA dehydrogenase deficiency (VLCAD) is an inherited metabolic disease and one of several mitochondrial fatty acid oxidation disorders. In agreement with the previous literature [2], Yamada and Taketani [1] state that VLCAD is inherited in an autosomal recessive pattern; however, we have a clinical case of a male with compound heterozygous pathogenic mutations in the ACADVL gene that has ubiquitously abnormal phenotype tests consistent with VLCAD diagnosis. We posit that VLCAD is not inherited in an autosomal recessive pattern and/or there are patients with a compound heterozygote genotype and a mild phenotype that should be formally recognized in research and clinical practice.

VLCAD is one of many inherited genotypes that present phenotypic responses in newborn patients and has been included in newborn screening worldwide since the 1990s. Although not diagnostic, newborn screening flags patients to undergo further diagnostic testing for VLCAD including: (1) acylcarnitine analysis using tandem mass spectrometry, (2) residual β-oxidation enzyme activity, and/or (3) genetic analysis. As demonstrated in Table 1, VLCAD has a clear and distinct phenotype and despite being a heterogeneous disorder, VLCAD can be clearly identified with an appropriate ensemble of diagnostic testing. The patient we observed clearly and ubiquitously has a phenotype consistent with VLCAD diagnosis (Table 1) based on robust and standard diagnostic clinical testing procedures. Tandem mass spectrometry was used to analyze acylcarnitine profiles at 31 h, 4, and 356 days of life, and each acylcarnitine profile demonstrated a phenotype consistent with VLCAD diagnosis. Using intact fibroblasts extracted from a skin biopsy at 4 days of life, triplicate radio-high-performance liquid chromatography of the β-oxidation acyl-3H-carnitine intermediates derived from palmitate, branched-chain amino acids and 3H-carnitine revealed marked elevations in concentrations of myristyl-(C14)- and palmityl-(C16)-carnitines and low concentrations of acetyl-(C2)-carnitine, consistent with a VLCAD phenotype (Table 1).

Table 1 Phenotype characteristics of VLCAD on screening and diagnostic clinical analyses
Full size table

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Yamada K, Taketani T. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency. J Hum Genet. 2019;64:73–85.

    Article  CAS  Google Scholar 

  2. Boneh A, Andresen BS, Gregersen N, Ibrahim M, Tzanakos N, Peters H, et al. VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. Mol Genet Metab. 2006;88:166–70.

    Article  CAS  Google Scholar 

  3. Andresen BS, Olpin S, Poorthuis BJ, Scholte HR, Vianey-Saban C, Wanders R, et al. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet. 1999;64:479–94.

    Article  CAS  Google Scholar 

  4. Andresen BS, Bross P, Vianey-Saban C, Divry P, Zabot MT, Roe CR, et al. Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene. Hum Mol Genet. 1996;5:461–72.

    Article  Google Scholar 

  5. Goetzman ES, Wang Y, He M, Mohsen AW, Ninness BK, Vockley J. Expression and characterization of mutations in human very long-chain acyl-CoA dehydrogenase using a prokaryotic system. Mol Genet Metab. 2007;91:138–47.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Jameson Senefeld for assistance with data collection and the clinical team at the Children’s Hospital of Wisconsin, including Drs Daniel Dorrington and William Rhead. We thank the Wisconsin State Laboratory of Hygiene for performing newborn screening, Prevention Genetics Laboratory for performing ACADVL genetic sequencing, and Dr William Rhead’s laboratory for performing residual β-oxidation enzyme activity testing.

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA

    Carly M. Senefeld

  2. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA

    Jonathon W. Senefeld

Authors
  1. Carly M. Senefeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathon W. Senefeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathon W. Senefeld.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Senefeld, C.M., Senefeld, J.W. Very long-chain acyl-CoA dehydrogenase deficiency nomenclature: compound heterozygosity. J Hum Genet 65, 435–436 (2020). https://doi.org/10.1038/s10038-020-0727-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-020-0727-9

Search

Advanced search

Quick links